arrow
K

Kari Kuulasmaa

finnish institute of health and welfare
H指数:92
被引数:5.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Occurrence of Coronary Events in the Absence of Traditional Risk Factors: Understanding Residual Risk (Arnold et al. Biomarker-related coronary risk in the community)

在缺乏传统风险因素的情况下冠状动脉事件的发生:理解残余风险(Arnold等.社区中生物标志物相关的冠状动脉风险)

2025-08-090
OAAI
Lipoprotein (a) and incident coronary heart disease in the community: impact of traditional cardiovascular risk factors

脂蛋白(a)与社区中冠心病的发生:传统心血管危险因素的影响

2025-07-013
OAAI
Cardiovascular disease outcomes in relation to 25-hydroxyvitamin D and its seasonal variation: Results from the BiomarCaRE consortium

与25-羟基维生素D及其季节性变化相关的心血管疾病结局:BiomarCaRE联盟的研究结果

2025-04-240
OA
Traditional modifiable cardiovascular risk factors and the risk of future CHD in the general population: an attempt towards better understanding residual risk

传统可改变的心血管危险因素与普通人群未来冠心病风险:对残余风险更深入理解的尝试

2024-11-120
PRE
Prognostic Value of Cardiovascular Biomarkers in the Population

心血管生物标志物在人群中的预后价值

2024-06-1113
OA
Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults

2022年1990年体重不足和肥胖的全球趋势: 对2.22亿名儿童、青少年和成人的3663项人口代表性研究的汇总分析

LANCET
IF88.5
2024-03-01296
OAAI
C-reactive protein modifies lipoprotein(a)-related risk for coronary heart disease: the BiomarCaRE project
2024-01-1810
PRE
Regional and temporal differences in the associations between cardiovascular disease and its classic risk factors: an analysis of 49 cohorts from 11 European countries
2023-11-176
PRE
An arrhythmogenic metabolite in atrial fibrillation
2023-08-243
OAAI
Drinking alcohol in moderation is associated with lower rate of all-cause mortality in individuals with higher rather than lower educational level: findings from the MORGAM project
2023-06-307
PRE
Biomarker-based prediction of fatal and non-fatal cardiovascular outcomes in individuals with diabetes mellitus
2023-04-205
PRE
Risk prediction of atrial fibrillation and its complications in the community using hs troponin I
2023-01-170
OA
Exploring the incremental utility of circulating biomarkers for robust risk prediction of incident atrial fibrillation in European cohorts using regressions and modern machine learning methods

使用回归和现代机器学习方法探索循环生物标志物对欧洲队列中房颤事件的稳健风险预测的增量效用

2023-01-0410
OAAI
Risk Factors, Subsequent Disease Onset, and Prognostic Impact of Myocardial Infarction and Atrial Fibrillation
2022-04-0510
OAAI
Association of glycated hemoglobin A1c levels with cardiovascular outcomes in the general population: results from the BiomarCaRE (Biomarker for Cardiovascular Risk Assessment in Europe) consortium
2021-11-1529
OAAI
Diabetes status-related differences in risk factors and mediators of heart failure in the general population: results from the MORGAM/BiomarCaRE consortium
2021-09-287
OAAI
Natriuretic Peptides and Risk of Type 2 Diabetes: Results From the Biomarkers for Cardiovascular Risk Assessment in Europe (BiomarCaRE) Consortium
2021-09-1412
OA